These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27221450)

  • 1. [No fear of pregnancy].
    Stiefelhagen P
    MMW Fortschr Med; 2016 May; 158(10):88. PubMed ID: 27221450
    [No Abstract]   [Full Text] [Related]  

  • 2. Preconceptional Counselling of IBD Patients.
    van der Woude CJ; Kanis SL
    J Crohns Colitis; 2016 Aug; 10(8):871-2. PubMed ID: 27208387
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?
    de Boer NK; de Meij T; van Bodegraven AA
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):669-71. PubMed ID: 24134152
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inflammatory bowel disease and possible applications of tumor necrosis factor inhibitors in pregnant women].
    Li ED
    Eksp Klin Gastroenterol; 2013; (3):58-62. PubMed ID: 24294773
    [No Abstract]   [Full Text] [Related]  

  • 5. Holoprosencephaly in a fetus with maternal medication of sulfasalazine in early gestation. A case report.
    Koyama N; Komori S; Bessho T; Koyama K; Hiraumi Y; Maeda Y
    Clin Exp Obstet Gynecol; 1996; 23(3):136-40. PubMed ID: 8894319
    [No Abstract]   [Full Text] [Related]  

  • 6. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.
    Zelinkova Z; de Haar C; de Ridder L; Pierik MJ; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
    Aliment Pharmacol Ther; 2011 May; 33(9):1053-8. PubMed ID: 21366638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
    Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory bowel disease and pregnancy].
    Parfenov AI
    Eksp Klin Gastroenterol; 2012; (3):80-6. PubMed ID: 22830229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory bowel disease and pregnancy].
    Hovdenak N; Schlichting E
    Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1201-3. PubMed ID: 9567697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of inflammatory bowel disease.
    Jafri SM
    J Pak Med Assoc; 1990 Jul; 40(7):162-7. PubMed ID: 2125661
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
    Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
    Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Management in the Pregnant IBD Patient.
    Saha S
    Am J Gastroenterol; 2017 May; 112(5):667-669. PubMed ID: 28220777
    [No Abstract]   [Full Text] [Related]  

  • 13. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy.
    Hutson JR; Matlow JN; Moretti ME; Koren G
    J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
    Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
    Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of inflammatory bowel diseases in pregnancy and lactation.
    Cassina M; Fabris L; Okolicsanyi L; Gervasi MT; Memmo A; Tiboni GM; Di Gianantonio E; Clementi M
    Expert Opin Drug Saf; 2009 Nov; 8(6):695-707. PubMed ID: 19832551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. My treatment approach to management of the pregnant patient with inflammatory bowel disease.
    Ng SW; Mahadevan U
    Mayo Clin Proc; 2014 Mar; 89(3):355-60. PubMed ID: 24582194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception.
    O'Donnell S; O'Morain C
    Aliment Pharmacol Ther; 2008 May; 27(10):885-94. PubMed ID: 18284649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease and preterm delivery.
    Wispelwey BP; Sheiner E
    Arch Gynecol Obstet; 2013 Oct; 288(4):725-30. PubMed ID: 23934241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and rheumatic diseases.
    Malviya AN
    J Assoc Physicians India; 1994 Feb; 42(2):178. PubMed ID: 7860501
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of inflammatory bowel disease during pregnancy and nursing.
    Friedman S
    Semin Gastrointest Dis; 2001 Oct; 12(4):245-52. PubMed ID: 11726078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.